| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > Has the Internet Killed Off the Direct Mail Baron? |
|
Advice You - Has the Internet Killed Off the Direct Mail Baron?
Over the past 30 years, direct mail has been responsible for generating vast amounts of money for businesses and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product individuals alike, but is it still an effective means of marketing? The short answer, in the short term, is yes. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in But the Internet has without doubt diluted the power of pen on paper and will continue to do so, until only a fe lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. w die-hard individuals and the glossy brochure brigade, are left to pick the bones of an industry once plump and here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ripe for plucking and plundering. Today, the Internet offers the consumer a pure, unadulterated and convenient e d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nvironment for buying goods, services, bill paying and browsing. And with more people logging on every day, it’s ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc where businesses need to focus. Compared to direct mail, marketing a business or service on the internet is simp easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e, very cost-effective and can be just as profitable. If it’s the ‘right’ kind of business, offering the ‘right’ nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically kind of product or service, it can prove to be overwhelmingly prosperous. And there’s many an Internet millionair and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e that will testify to that. The big advantage, in terms of doing business on the Internet, falls right at the f ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eet of the little guy. The one-man outfit, who has virtually no overheads and no employees. Better off still, is ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the little guy with no overheads, employees, products or services. He can make a phenomenal amount of money by se dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lling other people’s products for commissions. That’s quite difficult to do with direct mail and would likely pr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ove prohibitively expensive to operate. And that’s another reason why direct mail is in decline. The overall expe tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen se of the operation. When you add up the cost of stationery, printing, postage, mailing lists and the labor invo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel lved in the whole process, it’s clear to see that the ‘end is nigh’, for what was once a very lucrative marketing ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust venture. That’s not to say that there isn’t still a place for some forms of direct mail. Some online businesses, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products especially the bigger companies, would do well to incorporate a direct mail strategy in promoting their online a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ctivities. But generally, the opportunity of making a killing with direct mail is fading fast. So it’s goodbye t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o the direct mail baron and welcome to the Internet marketing guru. It’s the same animal but with different spots tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:You Have QuickBooks - Now What? Branding and Business Identity - Image is Everything! Is the Slowing Economy GOOD for Older Managers?
|